Detalhe da pesquisa
1.
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
Int J Cancer
; 152(9): 1894-1902, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562310
2.
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
BMC Cancer
; 23(1): 710, 2023 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516867
3.
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
J Natl Compr Canc Netw
; 21(12): 1234-1242.e17, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081120
4.
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Int J Cancer
; 151(11): 1978-1988, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833561
5.
Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.
Cancer
; 128(3): 435-446, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735022
6.
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
N Engl J Med
; 381(4): 317-327, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157963
7.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med
; 379(25): 2395-2406, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575490
8.
Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma.
Pancreatology
; 2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090806
9.
Management of BRCA Mutation Carriers With Pancreatic Adenocarcinoma.
J Natl Compr Canc Netw
; 19(4): 469-473, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845459
10.
FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life Study.
Oncologist
; 25(11): e1701-e1710, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886823
11.
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor.
Neuroendocrinology
; 110(1-2): 83-91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31071715
12.
The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors.
Neuroendocrinology
; 110(11-12): 967-976, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791037
13.
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours.
Neuroendocrinology
; 110(5): 404-412, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430756
14.
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
J Pathol
; 248(1): 51-65, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575030
15.
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.
Br J Cancer
; 120(7): 697-702, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30837681
16.
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Gastroenterology
; 154(4): 1061-1065, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158190
17.
Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.
Clin Genet
; 96(6): 579-584, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432501
18.
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses.
Neuroendocrinology
; 108(4): 343-353, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759445
19.
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
Int J Cancer
; 143(8): 2053-2064, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756206
20.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet
; 389(10073): 1011-1024, 2017 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129987